UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 34

Sortiert nach

Prevalencia de miastenia gravis en la comarca de Osona (Barcelona, Cataluña)

Neurología (Barcelona, Spain), 2017-01, Vol.32 (1), p.1-5

2017

Link zum Volltext

Verfügbarkeit prüfen

Onset-adjusted incidence of multiple sclerosis in the Girona province (Spain): Evidence of increasing risk in the south of Europe

Journal of the neurological sciences, 2015-12, Vol.359 (1), p.146-150

2015

Link zum Volltext

Verfügbarkeit prüfen

Increase in the prevalence of multiple sclerosis over a 17-year period in Osona, Catalonia, Spain

Multiple sclerosis, 2013-02, Vol.19 (2), p.245-248

2013

Link zum Volltext

Verfügbarkeit prüfen

Prevalence of myasthenia gravis in the Catalan county of Osona

Neurologia (Barcelona, Spain), 2017-01, Vol.32 (1), p.1

2017

Link zum Volltext

Verfügbarkeit prüfen

Myasthenia gravis: a higher than expected incidence in the elderly

Neurology, 2003-03, Vol.60 (6), p.1024

2003

Link zum Volltext

Verfügbarkeit prüfen

Prevalence of myasthenia gravis in the Catalan county of Osona

Neurología (Barcelona, English ed. ), 2017-01, Vol.32 (1), p.1-5

2017

Link zum Volltext

Verfügbarkeit prüfen

Genetic and environmental factors that may influence in the senile form of Alzheimer's disease: nested case control studies

Neurología (Barcelona, Spain), 2009-03, Vol.24 (2), p.108-112

2009

Link zum Volltext

Verfügbarkeit prüfen

Conducta simbólica y neuroplasticidad: ¿un ejemplo de coevolución gen-cultura?

Revista de neurologiá, 2004-07, Vol.39 (1), p.48

2004

Link zum Volltext

Verfügbarkeit prüfen

Prevalence of multiple sclerosis in the region of Osona, Catalonia, northern Spain

Journal of neurology, neurosurgery and psychiatry, 1995-05, Vol.58 (5), p.577-581

1995

Link zum Volltext

Verfügbarkeit prüfen

Prevalence of cognitive deterioration in people over 80-years-old: COGMANLLEU study

Neurología (Barcelona, Spain), 2009-03, Vol.24 (2), p.102-107

2009

Link zum Volltext

Verfügbarkeit prüfen

Alzheimer's disease and brain evolution: is Alzheimer's disease an example of antagonistic pleiotropy?

Revista de neurologiá, 2006-01, Vol.42 (1), p.25-33

2006

Link zum Volltext

Verfügbarkeit prüfen

Are symbolic behaviour and neuroplasticity an example of gene-culture coevolution?

Revista de neurologiá, 2004-07, Vol.39 (1), p.48-55

2004

Link zum Volltext

Verfügbarkeit prüfen

Apolipoprotein E polymorphism and neuronal plasticity

American journal of human biology, 2006-07, Vol.18 (4), p.556-558

2006

Link zum Volltext

Verfügbarkeit prüfen

Transferrin C2 allele, haemochromatosis gene mutations, and risk for Alzheimer's disease

Journal of neurology, neurosurgery and psychiatry, 2002-06, Vol.72 (6), p.820-821

2002

Link zum Volltext

Verfügbarkeit prüfen

Deletion of 17p11.2 chromosome in Spanish families with hereditary neuropathy and abnormal sensitivity to pressure

Neurología (Barcelona, Spain), 1995-11, Vol.10 (9), p.367-374

1995

Link zum Volltext

Verfügbarkeit prüfen

Patient-reported predictors of early treatment discontinuation: treatment-related symptoms and health-related quality of life among postmenopausal women with primary breast cancer randomized to anastrozole or exemestane on NCIC Clinical Trials Group (CCTG) MA.27 (E1Z03)

Breast cancer research and treatment, 2018-06, Vol.169 (3), p.537-548

2018

Link zum Volltext

Verfügbarkeit prüfen

Type B Lactic Acidosis in a Patient with Mantle Cell Lymphoma

Case reports in critical care, 2023, Vol.2023, p.1-5

2023

Link zum Volltext

Verfügbarkeit prüfen

Phase II Trial of Erlotinib and Docetaxel in Advanced and Refractory Hepatocellular and Biliary Cancers: Hoosier Oncology Group GI06‐101

The oncologist (Dayton, Ohio), 2012-01, Vol.17 (1), p.13-e23

2012

Link zum Volltext

Verfügbarkeit prüfen

Lung sarcomatoid carcinoma (LSC) harbors targetable genomic alterations and high mutational burden as observed by comprehensive genomic profiling (CGP)

Annals of oncology, 2016-10, Vol.27, p.vi419-vi419

2016

Link zum Volltext

Verfügbarkeit prüfen

Randomized, Double-Blinded, Multicenter, Phase II Study of Pemetrexed, Carboplatin, and Bevacizumab with Enzastaurin or Placebo in Chemonaïve Patients with Stage IIIB/IV Non-small Cell Lung Cancer: Hoosier Oncology Group LUN06-116

Journal of thoracic oncology, 2010-11, Vol.5 (11), p.1815-1820

2010

Link zum Volltext

Verfügbarkeit prüfen

Phase II and gene expression analysis trial of neoadjuvant capecitabine plus irinotecan followed by capecitabine-based chemoradiotherapy for locally advanced rectal cancer: Hoosier Oncology Group GI03-53

Cancer chemotherapy and pharmacology, 2012-07, Vol.70 (1), p.25-32

2012

Link zum Volltext

Verfügbarkeit prüfen

A phase I study of amrubicin (AMR) and cyclophosphamide in patients with advanced solid organ malignancies: A trial from the Hoosier Oncology Group

Journal of clinical oncology, 2011-05, Vol.29 (15_suppl), p.7082-7082

2011

Link zum Volltext

Verfügbarkeit prüfen

Phase I study of everolimus (RAD001) with irinotecan (Iri) and cetuximab (C) in second-line metastatic colorectal cancer: Hoosier Oncology Group GI05-102

Journal of clinical oncology, 2011-02, Vol.29 (4_suppl), p.523-523

2011

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 34

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(32)
Mit Volltextzugriff
(28)

Publikationsform

Sprache

Englisch
(23)
Spanisch
(12)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Prevalencia de miastenia gravis en la comarca de Osona (Barcelona, Cataluña)

Onset-adjusted incidence of multiple sclerosis in the Girona province (Spain): Evidence of increasing risk in the south of Europe

Increase in the prevalence of multiple sclerosis over a 17-year period in Osona, Catalonia, Spain

Prevalence of myasthenia gravis in the Catalan county of Osona

Myasthenia gravis: a higher than expected incidence in the elderly

Prevalence of myasthenia gravis in the Catalan county of Osona

Genetic and environmental factors that may influence in the senile form of Alzheimer's disease: nested case control studies

Conducta simbólica y neuroplasticidad: ¿un ejemplo de coevolución gen-cultura?

Situación epidemiológica actual de la esclerosis múltiple: pertinencia y puesta en marcha de un registro poblacional de nuevos casos en Cataluña

Prevalence of multiple sclerosis in the region of Osona, Catalonia, northern Spain

Prevalence of cognitive deterioration in people over 80-years-old: COGMANLLEU study

Alzheimer's disease and brain evolution: is Alzheimer's disease an example of antagonistic pleiotropy?

Are symbolic behaviour and neuroplasticity an example of gene-culture coevolution?

Apolipoprotein E polymorphism and neuronal plasticity

Transferrin C2 allele, haemochromatosis gene mutations, and risk for Alzheimer's disease

Deletion of 17p11.2 chromosome in Spanish families with hereditary neuropathy and abnormal sensitivity to pressure

Patient-reported predictors of early treatment discontinuation: treatment-related symptoms and health-related quality of life among postmenopausal women with primary breast cancer randomized to anastrozole or exemestane on NCIC Clinical Trials Group (CCTG) MA.27 (E1Z03)

Type B Lactic Acidosis in a Patient with Mantle Cell Lymphoma

Phase II Trial of Erlotinib and Docetaxel in Advanced and Refractory Hepatocellular and Biliary Cancers: Hoosier Oncology Group GI06‐101

Lung sarcomatoid carcinoma (LSC) harbors targetable genomic alterations and high mutational burden as observed by comprehensive genomic profiling (CGP)

Randomized, Double-Blinded, Multicenter, Phase II Study of Pemetrexed, Carboplatin, and Bevacizumab with Enzastaurin or Placebo in Chemonaïve Patients with Stage IIIB/IV Non-small Cell Lung Cancer: Hoosier Oncology Group LUN06-116

Phase II and gene expression analysis trial of neoadjuvant capecitabine plus irinotecan followed by capecitabine-based chemoradiotherapy for locally advanced rectal cancer: Hoosier Oncology Group GI03-53

Clinical Utility of Comprehensive Profiling of Genomic Alterations in Hematologic Malignancies

A phase I study of amrubicin (AMR) and cyclophosphamide in patients with advanced solid organ malignancies: A trial from the Hoosier Oncology Group

Phase I study of everolimus (RAD001) with irinotecan (Iri) and cetuximab (C) in second-line metastatic colorectal cancer: Hoosier Oncology Group GI05-102

Suchergebnisse filtern